Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
Bergmann L, Berns B, Dalgleish AG, von Euler M, Hecht TT, Lappin GL, Reed N, Palmeri S, Smyth J, Embacher-Aichorn S, Zwierzina H; Biotherapy Development Association.
Bergmann L, et al.
Ann Oncol. 2010 Aug;21(8):1573-1578. doi: 10.1093/annonc/mdq018. Epub 2010 Feb 4.
Ann Oncol. 2010.
PMID: 20133383
Free PMC article.
Review.